Top Stories
PTI
Published On Aug 8, 2023 at 06:30 PM IST
New Delhi: The Central Drugs Standard Control Organisation (CDSCO), along with state licensing authorities, has conducted risk-based inspections of 162 pharmaceutical firms, resulting in show cause notices issued in 143 cases, according to Union Health Minister Mansukh Mandaviya. Out of these, stop production orders were issued in 40 cases, while 66 cases saw cancellation or suspension of product/section licenses. Additionally, warning letters were sent in 21 cases, and in one instance, an FIR was lodged, leading to three arrests under the Drugs Rules, 1945.
A notification by the Directorate General of Foreign Trade mandated cough syrup manufacturers to obtain a certificate of analysis from a government-approved laboratory before exporting their products. Over 900 cough syrup samples have been analyzed and issued a Certificate of Analysis (CoA) as of now.
The manufacturing, sale, and distribution of drugs in India fall under the purview of the Drugs and Cosmetics Act, 1940, and Rules, 1945. Regulatory control involves licensing and inspection by State Licensing Authorities (SLAs) appointed by respective state governments. Manufacturers must adhere to license conditions for drug production, and when quality or safety issues arise, SLAs take appropriate action, including legal prosecution.
During a distressing week-long ordeal, a doctor based in Pune faced threats of identity theft and involvement in drug trafficking and money laundering.
Bengaluru: Rainbow Children's Medicare Limited (RCML), also known as Rainbow Children's Hospital, has officially launched a new 100-bed state-of-the-art spoke hospital at Sarjapur Road, Bengaluru, further strengthening its position as India's leading pediatric multi-specialty hospital chain.
Originating from modest roots in Andhra Pradesh, India, Dr. Sajja's journey epitomizes perseverance and commitment.
NATHEALTH, the apex body representing India's healthcare industry, has announced its new leadership team for the fiscal year 2023-24. Abhay Soi, Chairman and Managing Director of Max Healthcare Institute Limited, has been appointed as the new President for FY 2024-25, succeeding Dr. Ashutosh Raghuvanshi.
Gurugram (Haryana): Medanta Becomes the First Indian Hospital to Deploy AI-Enabled Penumbra Lightning Technology for Pulmonary Embolism Treatment.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, etc.
